NCT00398112 2014-05-14Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNational Cancer Institute (NCI)Phase 2 Completed18 enrolled 9 charts